Reaction Details | |||
---|---|---|---|
Report a problem with these data | |||
Target | Prostaglandin D2 receptor 2 | ||
Ligand | BDBM50401126 | ||
Substrate/Competitor | n/a | ||
Meas. Tech. | ChEMBL_884446 (CHEMBL2212208) | ||
IC50 | 11±n/a nM | ||
Citation | Kaila, N; Huang, A; Moretto, A; Follows, B; Janz, K; Lowe, M; Thomason, J; Mansour, TS; Hubeau, C; Page, K; Morgan, P; Fish, S; Xu, X; Williams, C; Saiah, E Diazine indole acetic acids as potent, selective, and orally bioavailable antagonists of chemoattractant receptor homologous molecule expressed on Th2 cells (CRTH2) for the treatment of allergic inflammatory diseases. J Med Chem55:5088-109 (2012) [PubMed] Article | ||
More Info.: | Get all data from this article, Assay Method | ||
Prostaglandin D2 receptor 2 | |||
Name: | Prostaglandin D2 receptor 2 | ||
Synonyms: | CD_antigen=CD294 | CRTH2 | Chemoattractant Receptor-homologous molecule expressed on T-helper type 2 cells (CRTH2) | Chemoattractant receptor-homologous molecule expressed on Th2 cells | Chemoattractant receptor-homologous molecule expressed on Th2 cells (CRTH2) | DL1R | G protein-coupled receptor 44 | G-protein coupled receptor 44 | GPR44 | PD2R2_HUMAN | PTGDR2 | Prostaglandin D2 | Prostaglandin D2 receptor 2 | Prostaglandin D2 receptor 2 (PGD2) | ||
Type: | Enzyme | ||
Mol. Mass.: | 43295.45 | ||
Organism: | Homo sapiens (Human) | ||
Description: | Q9Y5Y4 | ||
Residue: | 395 | ||
Sequence: |
| ||
BDBM50401126 | |||
n/a | |||
Name | BDBM50401126 | ||
Synonyms: | CHEMBL2204493 | ||
Type | Small organic molecule | ||
Emp. Form. | C26H20ClN3O3 | ||
Mol. Mass. | 457.908 | ||
SMILES | Cc1c(-c2nn(Cc3ccccc3)c(=O)c3ccccc23)c2cc(Cl)ccc2n1CC(O)=O |(23.87,-56.05,;22.33,-56.05,;21.42,-54.8,;22.14,-53.44,;23.68,-53.39,;24.41,-52.03,;25.95,-51.98,;26.76,-53.28,;26.03,-54.64,;26.85,-55.94,;28.39,-55.89,;29.11,-54.52,;28.29,-53.22,;23.59,-50.72,;24.31,-49.36,;22.04,-50.79,;21.23,-49.49,;19.7,-49.55,;18.98,-50.91,;19.8,-52.2,;21.32,-52.14,;19.94,-55.28,;18.61,-54.51,;17.28,-55.28,;15.94,-54.51,;17.27,-56.83,;18.61,-57.6,;19.94,-56.83,;21.42,-57.31,;22.14,-58.67,;21.31,-59.98,;19.77,-59.92,;22.03,-61.34,)| | ||
Structure |